ArticleTherapeutic advances in chronic disease2020

CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis.

Jeroen Fj Bogie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.